Winnipeg Free Press - ONLINE EDITION
Posted: 07/2/2013 12:51 PM | Comments: 0
Winnipeg medical device company, Miraculins Inc., has acquired a diabetes screening technology that measures changes in the composition of a person’s skin that indicates pre-diabetes and type 2 diabetes.
The non-invasive technology called Scout DS has received regulatory approval by Health Canada to be sold in Canada and is also cleared by the European Union and Mexico.
Miraculins’ CEO Christopher Moreau, said the acquisition of the Scout technology creates a number synergies for his company. That’s because Miraculins also makes and distributes a non-invasive screening kit that measures level of skin cholesterol called Pre-Vu.
It is the world’s first and only skin cholesterol test to assist with coronary artery disease risk assessment and detection. Pre-Vu is currently being tested at a number of London Drugs locations in Western Canada as well as PharmaChoice pharmacies in Eastern Canada,
The acquisition of Scout will be paid for through the release of shares in Miraculins to VeraLight staged to coincide with milestone events in the distribution and revenue generated from Scout, as well as an upfront payment of $150,000 in cash.
If all of the sales milestones are reached, VeraLight could ultimately owns as much as 19.9 per cent of Miraculins.
Having problems with the form?Contact Us Directly
Provincial ombudsmen express concern over anti-terrorism bill
Pallister compares NDP to Ringling Brothers
Three charged after drugs found in Portage la Prairie home
Eadie blasts frontage levy as unfair
Light snow expected, warmer temperatures for the weekend
Public's input sought on chief's job description
Missing St. Laurent teen last seen in Winnipeg
Man admits to serious assaults
On road to clarity for doctors
Seven years for sexual attack
Homeless, mentally ill get to work on creativity
Ashton sees win on second ballot
Kinsmen seek assurances for city pool
Reporter's Sinclair coverage recognized
Need for shelter never wanes
Timeline of a tragedy: The Candace Derksen case
Audit needed to find blame for stadium fiasco
Birth tops for hospitalization
New trial for convicted killer
Shocked by modern medicine
Another delegate controversy
'One day at a time,' mother pledges
Vaccination best way to avoid painful shingles
Newcomers getting help in drive for independence
Lawyer suspended over misconduct